The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

In South Dallas, a local nonprofit is working to address disparities that affect life expectancy and heart disease outcomes ...

Advanced adenomas were associated with an increased risk of all-cause mortality, a cohort study from Minnesota found. (JAMA ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

Yet the majority (60%) have not formally disclosed their conditions to their employer.

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...